Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Crick Startup Careers Fair

The Crick Startup Career Fair is an opportunity for early-career researchers to explore careers beyond academia and connect with pioneering startups in biosciences and health [...]

Go to Top